Skip to content

Clinical trials

End Stage Liver Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: End Stage Liver Disease Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20123
20151
20182
20191
20211
20221
20231
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status8
Recruiting4
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Air Force Military Medical University, China3
Tongji Hospital3
RenJi Hospital2
Beijing Chao Yang Hospital1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
General Hospital of Shenyang Military Region1
Huashan Hospital1
Nanfang Hospital, Southern Medical University1
Xijing Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
End Stage Liver Disease14
Liver Cirrhosis3
Acute-On-Chronic Liver Failure2
Infections2
Liver Failure2
Fatty Liver1
Fibrosis1
Hypertension, Portal1
Jaundice1
Liver Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.